These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 20540847)

  • 1. [A control study of aripiprazole and tiapride treatment for tic disorders in children].
    Liu YY; Chen YH; Chen H; Liu ZS
    Zhongguo Dang Dai Er Ke Za Zhi; 2010 Jun; 12(6):421-4. PubMed ID: 20540847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A multicenter controlled study on aripiprazole treatment for children with Tourette syndrome in China].
    Liu ZS; Chen YH; Zhong YQ; Zou LP; Wang H; Sun D; Wang DB; Liao JX
    Zhonghua Er Ke Za Zhi; 2011 Aug; 49(8):572-6. PubMed ID: 22093417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An open-label study of the efficacy and tolerability of aripiprazole for children and adolescents with tic disorders.
    Yoo HK; Choi SH; Park S; Wang HR; Hong JP; Kim CY
    J Clin Psychiatry; 2007 Jul; 68(7):1088-93. PubMed ID: 17685747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical effectiveness of aripiprazole in short-term treatment of tic disorder in children and adolescents: a naturalistic study.
    Ho CS; Chiu NC; Tseng CF; Huang YL
    Pediatr Neonatol; 2014 Feb; 55(1):48-52. PubMed ID: 23920131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness and tolerability of aripiprazole in children and adolescents with Tourette's disorder: a pilot study in China.
    Cui YH; Zheng Y; Yang YP; Liu J; Li J
    J Child Adolesc Psychopharmacol; 2010 Aug; 20(4):291-8. PubMed ID: 20807067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aripiprazole versus risperidone for treating children and adolescents with tic disorder: a randomized double blind clinical trial.
    Ghanizadeh A; Haghighi A
    Child Psychiatry Hum Dev; 2014 Oct; 45(5):596-603. PubMed ID: 24343476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjunctive low-dose aripiprazole with standard-dose sertraline in treating fresh major depressive disorder: a randomized, double-blind, controlled study.
    Lin CH; Lin SH; Jang FL
    J Clin Psychopharmacol; 2011 Oct; 31(5):563-8. PubMed ID: 21869699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Open-label study comparing the efficacy and tolerability of aripiprazole and haloperidol in the treatment of pediatric tic disorders.
    Yoo HK; Lee JS; Paik KW; Choi SH; Yoon SJ; Kim JE; Hong JP
    Eur Child Adolesc Psychiatry; 2011 Mar; 20(3):127-35. PubMed ID: 21188439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical observation of aripiprazole in the treatment of autism].
    Xie Q; Tang J; Xu Y; Zeng HL
    Zhongguo Dang Dai Er Ke Za Zhi; 2013 Apr; 15(4):294-7. PubMed ID: 23607954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aripiprazole treatment of children and adolescents with Tourette disorder or chronic tic disorder.
    Seo WS; Sung HM; Sea HS; Bai DS
    J Child Adolesc Psychopharmacol; 2008 Apr; 18(2):197-205. PubMed ID: 18439116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aripiprazole in the treatment of irritability in children and adolescents with autistic disorder.
    Owen R; Sikich L; Marcus RN; Corey-Lisle P; Manos G; McQuade RD; Carson WH; Findling RL
    Pediatrics; 2009 Dec; 124(6):1533-40. PubMed ID: 19948625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aripiprazole in children with Tourette's disorder and co-morbid attention-deficit/hyperactivity disorder: a 12-week, open-label, preliminary study.
    Masi G; Gagliano A; Siracusano R; Berloffa S; Calarese T; Ilardo G; Pfanner C; Magazù A; Cedro C
    J Child Adolesc Psychopharmacol; 2012 Apr; 22(2):120-5. PubMed ID: 22375853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A multicenter, randomized, double-blind, placebo-controlled study of aripiprazole in children and adolescents with Tourette's disorder.
    Yoo HK; Joung YS; Lee JS; Song DH; Lee YS; Kim JW; Kim BN; Cho SC
    J Clin Psychiatry; 2013 Aug; 74(8):e772-80. PubMed ID: 24021518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aripiprazole in children and adolescents with bipolar disorder comorbid with attention-deficit/hyperactivity disorder: a pilot randomized clinical trial.
    Tramontina S; Zeni CP; Ketzer CR; Pheula GF; Narvaez J; Rohde LA
    J Clin Psychiatry; 2009 Apr; 70(5):756-64. PubMed ID: 19389329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Open label aripiprazole in the treatment of youth with tic disorders.
    Murphy TK; Mutch PJ; Reid JM; Edge PJ; Storch EA; Bengtson M; Yang M
    J Child Adolesc Psychopharmacol; 2009 Aug; 19(4):441-7. PubMed ID: 19702496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aripiprazole for the tic symptoms in a child receiving atomoxetine treatment for ADHD.
    Yu SH; Chou JY; Robson D; Chen VC
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Oct; 34(7):1355-6. PubMed ID: 20619310
    [No Abstract]   [Full Text] [Related]  

  • 17. Aripiprazole for the treatment of tic disorders in children: a systematic review and meta-analysis.
    Yang CS; Huang H; Zhang LL; Zhu CR; Guo Q
    BMC Psychiatry; 2015 Jul; 15():179. PubMed ID: 26220447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Double-blind, randomized, placebo-controlled long-term maintenance study of aripiprazole in children with bipolar disorder.
    Findling RL; Youngstrom EA; McNamara NK; Stansbrey RJ; Wynbrandt JL; Adegbite C; Rowles BM; Demeter CA; Frazier TW; Calabrese JR
    J Clin Psychiatry; 2012 Jan; 73(1):57-63. PubMed ID: 22152402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized double-blind multicentre placebo-controlled clinical trial of the clonidine adhesive patch for the treatment of tic disorders.
    Du YS; Li HF; Vance A; Zhong YQ; Jiao FY; Wang HM; Wang MJ; Su LY; Yu DL; Ma SW; Wu JB
    Aust N Z J Psychiatry; 2008 Sep; 42(9):807-13. PubMed ID: 18696285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aripiprazole in children and adolescents with Tourette's disorder: an open-label safety and tolerability study.
    Lyon GJ; Samar S; Jummani R; Hirsch S; Spirgel A; Goldman R; Coffey BJ
    J Child Adolesc Psychopharmacol; 2009 Dec; 19(6):623-33. PubMed ID: 20035580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.